Agilent Technologies (A) Current Deferred Revenue (2009 - 2026)
Agilent Technologies' (A) quarterly Current Deferred Revenue came in at $640.0 million in Q3 2026, up 3.23% year-over-year from $620.0 million in Q3 2025, and down 3.76% quarter-over-quarter from $665.0 million in Q2 2026.
Analysis
Agilent Technologies (A) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Current Deferred Revenue for 18 consecutive years, with $640.0 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Current Deferred Revenue rose 3.23% year-over-year to $640.0 million in Q3 2026; TTM through Jul 2026 was $640.0 million, a 3.23% increase from a year earlier, with the FY2025 full-year figure at $624.0 million, up 14.71% from the prior year.
- Current Deferred Revenue was $640.0 million for Q3 2026 at Agilent Technologies, down from $665.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $682.0 million in Q1 2026 and troughed at $461.0 million in Q4 2022.
- A 5-year average of $558.6 million and a median of $524.0 million in 2024 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue climbed 19.11% in 2022 and climbed 0.19% in 2024, its largest moves.
- Over 5 years, Current Deferred Revenue stood at $461.0 million in 2022, then grew by 9.54% to $505.0 million in 2023, then grew by 7.72% to $544.0 million in 2024, then gained by 14.71% to $624.0 million in 2025, then gained by 2.56% to $640.0 million in 2026.
- The last three Current Deferred Revenue figures came in at $640.0 million (Q3 2026), $665.0 million (Q2 2026), and $682.0 million (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 640.00 Mn |
| Apr 30, 2026 | 665.00 Mn |
| Jan 31, 2026 | 682.00 Mn |
| Oct 31, 2025 | 624.00 Mn |
| Jul 31, 2025 | 620.00 Mn |
| Apr 30, 2025 | 628.00 Mn |
| Jan 31, 2025 | 612.00 Mn |
| Oct 31, 2024 | 544.00 Mn |
| Jul 31, 2024 | 524.00 Mn |
| Apr 30, 2024 | 533.00 Mn |
| Jan 31, 2024 | 522.00 Mn |
| Oct 31, 2023 | 505.00 Mn |
| Jul 31, 2023 | 512.00 Mn |
| Apr 30, 2023 | 519.00 Mn |
| Jan 31, 2023 | 521.00 Mn |
| Oct 31, 2022 | 461.00 Mn |
| Jul 31, 2022 | 498.00 Mn |
| Apr 30, 2022 | 511.00 Mn |
| Jan 31, 2022 | 493.00 Mn |
| Oct 31, 2021 | 441.00 Mn |